SERES THERAPEUTICS INC's ticker is MCRB and the CUSIP is 81750R102. A total of 125 filers reported holding SERES THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 1.01 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $1,630,000 | -75.6% | 475,121 | -49.5% | 0.01% | -71.1% |
| Q1 2022 | $6,694,000 | -37.7% | 940,131 | -27.1% | 0.04% | -37.5% |
| Q4 2021 | $10,748,000 | +1563.8% | 1,290,297 | +5554.0% | 0.07% | +928.6% |
| Q3 2020 | $646,000 | -42.3% | 22,821 | -90.3% | 0.01% | -41.7% |
| Q2 2020 | $1,120,000 | +47.8% | 235,307 | +10.8% | 0.01% | +20.0% |
| Q1 2020 | $758,000 | -34.1% | 212,379 | -36.3% | 0.01% | -9.1% |
| Q4 2019 | $1,150,000 | +82.5% | 333,396 | +112.2% | 0.01% | +37.5% |
| Q3 2019 | $630,000 | +170.4% | 157,133 | +117.4% | 0.01% | +166.7% |
| Q2 2019 | $233,000 | -82.7% | 72,280 | -63.2% | 0.00% | -84.2% |
| Q1 2019 | $1,349,000 | +113.1% | 196,383 | +40.2% | 0.02% | +72.7% |
| Q4 2018 | $633,000 | -36.0% | 140,083 | +7.5% | 0.01% | -21.4% |
| Q3 2018 | $989,000 | -17.6% | 130,283 | -6.6% | 0.01% | -26.3% |
| Q2 2018 | $1,200,000 | +84.3% | 139,484 | +57.3% | 0.02% | +72.7% |
| Q1 2018 | $651,000 | -28.1% | 88,684 | -0.6% | 0.01% | -31.2% |
| Q4 2017 | $905,000 | – | 89,218 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Flagship Pioneering Inc. | 23,117,045 | $55,018,567 | 3.99% |
| Lion Point Capital, LP | 691,803 | $1,646,491 | 0.73% |
| Eversept Partners, LP | 2,352,556 | $5,599,083 | 0.47% |
| Soleus Capital Management, L.P. | 1,820,983 | $4,333,940 | 0.40% |
| Simplify Asset Management Inc. | 550,626 | $1,310,490 | 0.15% |
| Avoro Capital Advisors LLC | 2,500,000 | $5,950,000 | 0.09% |
| IRONWOOD INVESTMENT MANAGEMENT LLC | 45,419 | $108,097 | 0.07% |
| Knott David M Jr | 70,000 | $167 | 0.06% |
| XTX Topco Ltd | 150,097 | $357,231 | 0.06% |
| FEDERATED HERMES, INC. | 8,981,717 | $21,376,486 | 0.06% |